Tags: Valeant | Salix | Pharmaceuticals | Drugs

Valeant Boosts Offer for Salix Pharma to About $11.11 Billion

Sunday, 15 Mar 2015 08:32 AM

Valeant is raising its offer for Salix Pharmaceuticals to about $11.11 billion, heating up a bidding fight for the company.

The Canadian drug maker's new bid is for $173 per Salix share, a 2 percent premium over Friday closing price of $169.40.

The companies put the deal's enterprise value at about $15.8 billion.

The new bid comes after an offer last week from specialty drugmaker Endo International PLC, which said it would pay 11 percent more for the company than Valeant Pharmaceuticals.

Valeant's prior offer was about $10 billion, or $158 per share. With debt, that deal was valued at $14.5 billion.

Shares of from Valeant Pharmaceuticals International Inc. and Salix Pharmaceuticals Ltd., which is based in Raleigh, North Carolina, are up in premarket trading Monday.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

 
1Like our page
2Share
Companies
Valeant is raising its offer for Salix Pharmaceuticals to about $11.11 billion, heating up a bidding fight for the company.The Canadian drug maker's new bid is for $173 per Salix share, a 2 percent premium over Friday closing price of $169.40.The companies put the deal's...
Valeant, Salix, Pharmaceuticals, Drugs
126
2015-32-15
Sunday, 15 Mar 2015 08:32 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved